Sign Out
Hypersensitivity to drospirenone or ethinylestradiol.
This medication should not be used in the presence of any of the conditions listed as follows. Should any of the conditions appear for the first time during use, the product should be stopped immediately: Adrenal insufficiency; Hepatic function or renal impairment or in patients with conditions that predispose to hyperkalemia; Known or suspected breast carcinoma, or endometrium carcinoma; Known or suspected estrogen-dependent neoplasia; Cardiac insufficiency; Active or history of cerebrovascular disease/coronary artery disease; Cholestatic jaundice of pregnancy or jaundice with prior pill use; Cholestatic hepatic disease; History of benign or malignant hepatic tumors; Pregnancy; If the patient has (or has in the past) thrombophlebitis, thrombosis or thromboembolic disorder; Abnormal or undiagnosed uterine bleeding; Hypertension; Diabetes mellitus.
